Ligand Pharmaceuticals (LGND) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.05% |
| Dec 31, 2025 | 238.07% |
| Sep 30, 2025 | -13.26% |
| Jun 30, 2025 | 160.74% |
| Mar 31, 2025 | -189.44% |
| Dec 31, 2024 | -74.21% |
| Sep 30, 2024 | 280.34% |
| Jun 30, 2024 | -429.33% |
| Mar 31, 2024 | 67.70% |
| Dec 31, 2023 | 120.12% |
| Sep 30, 2023 | 1,170.46% |
| Jun 30, 2023 | -101.40% |
| Mar 31, 2023 | -38.27% |
| Dec 31, 2022 | 93.34% |
| Sep 30, 2022 | 435.46% |
| Jun 30, 2022 | -88.78% |
| Mar 31, 2022 | 76.99% |
| Dec 31, 2021 | 9.77% |
| Sep 30, 2021 | 54.83% |
| Jun 30, 2021 | 46.90% |
| Mar 31, 2021 | 1,494.47% |
| Dec 31, 2020 | -94.71% |
| Sep 30, 2020 | -47.60% |
| Jun 30, 2020 | 43.26% |
| Mar 31, 2020 | 315.20% |
| Dec 31, 2019 | -27.53% |
| Sep 30, 2019 | -226.74% |
| Jun 30, 2019 | -89.22% |
| Mar 31, 2019 | 38.07% |
| Dec 31, 2018 | 19.96% |
| Sep 30, 2018 | -63.11% |
| Jun 30, 2018 | 21.09% |
| Mar 31, 2018 | 96.93% |
| Dec 31, 2017 | 18.90% |
| Sep 30, 2017 | 147.78% |
| Jun 30, 2017 | -45.27% |
| Mar 31, 2017 | 13.40% |
| Dec 31, 2016 | -13.66% |
| Sep 30, 2016 | 103.84% |
| Jun 30, 2016 | -25.54% |
| Mar 31, 2016 | -5.32% |
| Dec 31, 2015 | 30.30% |
| Sep 30, 2015 | 4.18% |
| Jun 30, 2015 | 32.16% |
| Mar 31, 2015 | -25.07% |
| Dec 31, 2014 | 170.92% |
| Sep 30, 2014 | -9.78% |
| Jun 30, 2014 | 60.99% |
| Mar 31, 2014 | -78.43% |
| Dec 31, 2013 | 2,007.20% |
| Sep 30, 2013 | -108.96% |
| Jun 30, 2013 | 241.84% |
| Mar 31, 2013 | 22.95% |
| Dec 31, 2012 | 278.11% |
| Sep 30, 2012 | -20.41% |
| Jun 30, 2012 | -99.48% |
| Mar 31, 2012 | -105.50% |
| Dec 31, 2011 | 705.06% |
| Sep 30, 2011 | 85.51% |
| Jun 30, 2011 | -987.97% |
| Mar 31, 2011 | 187.28% |
| Dec 31, 2010 | 86.48% |